Dianthus Therapeutics | Passifs Courants



Current Liabilities Changement Date
Adcock Ingram Holdings ZAR 2.81B 279.84M 2024-12
Alaunos Therapeutics USD 4K 822K 2024-10
Avita Medical AUD 20.16M 6.37M 2024-12
Celltrion KRW 3.4T 3.16T 2025-03
Cspc Pharmaceutical CNY 9.63B 801.28M 2024-12
Dianthus Therapeutics USD 18.45M 2.74M 2024-12
Divis Laboratories Ltd 14.52B 1.61B 2025-03
IQVIA Holdings USD 7.18B 222M 2025-03
Kangmei Pharma CNY 4.91B 208.41M 2024-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 156.65M 115.81M 2024-12
Malin Corporation EUR 500K 500K 2024-06
Medical Developments International AUD 9.55M 1.61M 2024-06
Moderna USD 1.6B 602M 2025-03
Neuren Pharmaceuticals AUD 45.76M 36.79M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Organon & Co USD 2.62B 103M 2025-03
Pharma Mar EUR 79.49M 3.2M 2025-03
Qiagen NV USD 543.63M 584.94M 2024-12
Revvity USD 648.19M 4.91M 2025-03
Sartorius EUR 1.48B 36.8M 2025-03
Sino Biopharmaceutical CNY 19.56B 2.39B 2024-12
Tectonic Therapeutic USD 11.61M 5.71M 2024-12
Tilray USD 278.52M 15.02M 2024-11
Viatris USD 5.72B 59.3M 2025-03
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12
Zz Pientze Pharmaceu 2.32B 49.86M 2025-03



Dianthus Therapeutics Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.